Lipopolysaccharide (LPS) endotoxin of Gram-negative bacteria compromises the integrity of the airway epithelial barrier and initiates migration of leukocytes across the epithelium. The goal of the present study was to identify the role of extracellular regulated kinase (ERK1/2) transduction pathways in these processes. The first aim was to determine whether LPS induces ERK1/2 activation and changes in epithelial permeability in epithelial cells alone or only in the presence of immune cells. The second aim was to determine whether the changes in the epithelial permeability were diminished by ERK1/2 blockade. The third aim was to investigate the role of protein kinase C (PKC) activation as an upstream event in activation of ERK1/2. In vitro 20 mg/ml LPS challenge reduced epithelial barrier function, and induced ERK1/2 phosphorylation in primary cultures of bovine tracheal epithelium and in the transformed human airway epithelial cell line, Calu-3. LPS initiated migration of neutrophil-like and monocyte-like transformed HL-60 cell across sheets of Calu-3 cells. The migration rate and the associated changes in the electrical resistance, permeability to albumin, and ERK1/2 phosphorylation were all blocked by calphostin C, the specific blocker of PKC and by PD98059 (2¢-amino-3¢methoxyflavone), a selective cell-permeable inhibitor of MAP kinase kinase. In rats, in vivo perfusion of the lumen of an isolated segment of trachea with LPS (0.1 mg/ml) initiated migration of neutrophils and increased the permeability to albumin. Again, these effects were markedly inhibited by PD98059 and calphostin C (by > 50%). We conclude that epithelial ERK1/2 is activated by endotoxin via PKC and is an important pathway in regulation of epithelial permeability.
INTRODUCTION
Inflammation of the upper respiratory tract is characterized by an increased permeability of the epithelial barrier and leukocyte migration into the airway lumen. 1, 2 Endotoxin (lipopolysaccharide, LPS) of Gram-negative bacteria is among the major factors which induce inflammation. [3] [4] [5] [6] [7] [8] [9] Both Gram-negative bacteria and endotoxin itself are known to activate epithelial cells to release an array of cytokines. 10, 11 However, the mechanisms of endotoxin action on permeability of the airway epithelial cell barrier have been little studied. 12 It is known that inflammationinduced epithelial leakiness is related to activation of protein kinase C (PKC) and its downstream effector pathways, [13] [14] [15] [16] though other pathways may be also involved. [17] [18] [19] [20] PKC-related signal transduction pathways include phosphorylation of mitogen-activated protein kinases (MAPK). 21 MAPKs are well known as an important transduction pathways of activation of many cell types in inflammation; 22 however, their role in activation of airway epithelial cells is unclear. 23 MAPKs are a family of serine/theonine kinases, three of which are relatively well characterized: extracellular signalregulated kinases (ERKs), Jun amino-terminal kinases (JNK), and p38 MAPK. 22 Studies of p38 kinase in lung inflammation demonstrated its involvement in inflammatory reaction in the lung. 24, 25 ERKs are activated in response to growth factors, and the pathway involved in ERK stimulation requires activation of Ras, Raf, and MAPK; they also can be activated by environmental stress. 21, 23 ERK can phosphorylate and activate myosin light-chain kinase, thus mediating myosin ATPase-dependent contraction of the perijunctional acto-myosin belt. Contraction of the perijunctional belt changes integrity of the tight junctions. 26 As permeability of the epithelium is determined by the status of tight junctions, 27 activation of ERK1/2 is likely to be important for regulation of epithelial barrier function. 28 Also, ERK1/2 plays an important role in transcriptional activation of multiple chemokines. 21, 22 The combination of released chemokines, leukocyte transmigration and breakdown of epithelial permeability is the hallmark of the inflammatory reaction in epithelia. [29] [30] [31] Here we describe the role of the ERK1/2 pathway in the reactions of airway epithelium to LPS.
We had three specific aims. First, to determine whether LPS induces ERK1/2 activation and changes in epithelial permeability in epithelial cells alone or only in the presence of immune cells. Second, to determine whether the changes in permeability are diminished by blockade of ERK1/2. Third, to investigate the role of PKC activation as an upstream event in activation of ERK1/2.
We performed experiments in vitro in a human airway epithelial cell line , and in primary cultures of bovine tracheal epithelial cells and in vivo in rat tracheas. LPS activates non-immune cells only at very high concentrations. Therefore, we used high LPS concentrations in cultures of epithelial cells, where immune cells were not present. To study the effects of LPS on the epithelial barrier function in vitro, we measured the rate of induced transmigration of the human promyelocytic cell line, HL-60, transepithelial electrical resistance, and permeability to albumin. We measured activation of ERK1/2 by LPS using immunocytochemistry and immunoblotting. To study pharmacologically the involvement of the protein kinase C (PKC) pathway, we used a specific blocker of PKC (calphostin C). We also determined the effect of flavone compound PD98059, a specific pharmacological cell-permeable blocker of ERK1/2. In vitro, LPS induced ERK1/2 phosphorylation in epithelial cells alone, initiated migration of HL-60 cells, and increased epithelial permeability via PKC-related pathways, effects that were partially blocked by ERK1/2-specific blockade. In vivo, we found an increase in the epithelial permeability following LPSinduced leukocyte migration that was reduced by PKC and ERK1/2 pharmacological blockade. Thus, we conclude that LPS decreases epithelial barrier function by a PKC-dependent activation of ERK1/2.
MATERIALS AND METHODS

Reagents
Calphostin C and PD98059 were from Calbiochem (San Diego, CA, USA). Calphostin C is a specific blocker of protein kinase C (IC 50 = 50 nM) that interacts with the protein's regulatory domain at the binding site of diacylglycerol and phorbol esters. PD98059 (2¢-amino-3¢methoxyflavone) is a selective cell-permeable inhibitor of MAP kinase kinase (MEK; IC 50 = 50 mM). Cells were labeled with green fluorochrome Calceine-AM (Molecular Probes, Eugene, OR, USA) or red fluorochrome aliphatic reporter PKH26 (Sigma Co., St Louis, MO, USA). PKH26 fluorescent linker provides phagocytic labeling of live cells; it is physiologically stable with no toxic effects. LPS (Escherichia coli O55:B5) was from Sigma. Monoclonal antibodies to total and phosphorylated ERK1/2 were from Cell Signaling Technologies (Beverly, MA, USA). Type Culture Collection  [ATCC] , Rockville, MD, USA) are a spontaneously transformed lung adenocarcinoma-derived cell line widely used for studies of barrier properties and electrolyte transport of the airway epithelium. Calu-3 cells and primary tracheal cultures both resemble native airway epithelium. Calu-3 cells were grown in a 1:1 mix of Dulbecco's modified Eagle's medium (DMEM) H-21 and Hank's F-12 mix supplemented with 15% (v/v) heatinactivated fetal calf serum (FCS; Invitrogen, Carlsbad, CA, USA), 100 U/ml penicillin (Invitrogen), and 100 mg/ml streptomycin (Invitrogen). Phenol red was omitted from the medium, as it interferes with fluorescence measurements. Cells (passages 10-30) were plated on the external surface of polycarbonate membranes (3.0mm pore size, 6.5 mm diameter) of inverted transwells (Costar, Cambridge, MA, USA). Cells were grown with an air-liquid interface, i.e. with medium added to the basolateral side (inside the inverted insert) for 18 days. Cell sheets by day 18 revealed transepithelial electrical resistance (TER) higher than 350 W·cm 2 . Confluence of cell sheets was also confirmed by Diff-Quik staining, light and scanning electron microscopy. Permeability to albumin was in the range of 10-15 x 10 -6 cm/s. Cells were used within 3 days of achieving confluence.
Cell culture
Calu-3 cell line
Calu-3 cells (American
Primary cultures of tracheal epithelial cells
Primary cultures were grown as previously described. 32, 33 The mucosal surface of cow tracheas was scored into thin strips and these were separated from the underlying cartilage rings and placed in cold phosphate-buffered saline (PBS) with a mix of penicillin, streptomycin, fungizone, and gentamycin (PSFG). Strips were placed in 40 ml of Hank's balanced salt solution (HBSS), Ca 2+ /Mg 2+ free + PSFG with 1 mg/ml protease (Sigma), and digested overnight at 4°C. Strips were then resuspended in DMEM H21/F-12 mix + 5% FCS + PSFG, and shaken vigorously to dislodge the cells. The cell suspension was centrifuged for 10 min at 200 g. The cells were plated at 10 6 cells/cm 2 on 3-mm pore polycarbonate membranes and grown in DMEM/F-12 with PSFG and a mixture of growth factors consisting of transferrin, insulin, tri-iodothyronine, hydrocortisone, endothelial cell growth supplement, and epidermal growth factor.
Calcein-AM and PKH26 labeling
To assess migration, HL-60 cells (10 7 /ml) were labeled with 5 mg/ml calcein-AM (Molecular Probes) for 30 min at 37°C as described previously. 34, 35 After labeling, the cells were washed three times with RPMI-1640 medium. Levels of calcein-AM were measured with a spectrofluorometer (model CytoFluor 2350, Millipore). PKH26 labeling was performed according to manufacturer's instructions.
Pharmacological studies
Epithelial cell sheets were incubated with drugs of interest (calphostin C, 10 -8 M; PD98059, 5 x 10 -5 M) for 1 h prior to addition of LPS. Drugs were added to both apical and basolateral sides, and removed by washing twice with fresh medium.
Migration experiments
To study transepithelial leukocyte migration, we used the HL-60 human promyelocytic cell line or freshly isolated human granulocytes. HL-60 cells (ATCC) were grown in suspension in RPMI-1640 with 10% FCS and were differentiated into neutrophil-like phenotype by treatment with retinoic acid (10 nM) for 4 days before the experiment, or differentiated into monocyte-like cells (stimulated with a-1,25 hydroxyvitamin D 3 ) as described. 36 We investigated stimulated migration induced by administration of endotoxin (LPS E. coli O55:B5; 0-20 mg/ml, 0-20 nM ) to the mucosal side of the epithelial layer in both serosal-tomucosal and reverse directions.
To study transmigration, transwells were returned to their normal orientation, washed twice before and after pharmacological treatment. Next, the outer (mucosal) compartment was filled with prewarmed medium with 10% FCS with or without LPS. The HL-60 cells or human granulocytes (2 x 10 5 cells in 0.2 ml of prewarmed incubation medium) were placed in the serosal compartment, and the transwells were incubated for 4-24 h at 37°C with 5% CO 2 and 95% humidity. The number of migrating cells was determined by flow cytometry (Flow-Calibur; Beckton-Dickinson, Oxnard, CA, USA) and/or by total fluorescence of cell suspension. To determine migration of labeled cells, we used a previously established technique. 34, 35 To correct for the possible presence of non-cell-associated fluorescence, medium with transmigrated cells was centrifuged at 3000 rpm for 15 min, the supernatant discarded and the cell pellet (~50 ml) was reconstituted to 0.5 ml and its fluorescence then measured. The percentage of leukocytes that had transmigrated was calculated from the amount of fluorescence detected in the fluid from the lower compartment in relation to the fluorescence of the total added labeled leukocytes. A calibration curve (fluorescence intensity versus number of labeled cells) was performed for each experiment and confirmed by flow cytometry or by cell counts with a hemocytometer.
Human granulocyte isolation
Granulocytes were obtained from citrate-buffered human blood. Blood was diluted 1:2 with Ca 2+ /Mg 2+ -free HBSS and cells were pelleted at 400 g for 20 min. The pellet was suspended in HBSS and layered on a discontinuous gradient of 1.119 and 1.077 g/ml Histopaque (Sigma). After centrifugation at 700 g for 30 min, the granulocyte band at the interface of the two densities was harvested and cells washed twice. Contaminating erythrocytes were removed by a standard hypotonic lysis step, and the granulocytes were resuspended in RPMI-1640 medium with 10% FCS to a final concentration of 5 x 10 6 cells/ml. The final suspension was more than 95% neutrophils, as confirmed by differential cell count.
Immunofluorescence
Specifically for these experiments, human granulocytes were stained with PKH26 (Sigma) according to the manufacturer's protocol. After 1-12 h of migration, filters with primary tracheal epithelial cell cultures were washed with PBS and fixed for 10 min in 4% paraformaldehyde. Fixed cells were then washed with PBS, exposed to cold methanol (-20°C) for 5 min, washed twice, exposed to 0.2% Triton X-100 in PBS for 5 min and then washed with PBS twice again. Filters were further blocked with 3% bovine serum albumin (BSA)/0.1% Tween 20 in 4x SSC buffer (0.15 M NaCl, 0.015 M trisodium citrate, pH 7.0) for 20 min. Mouse anti-human anti-phospho ERK1/2 antibody (1:500 in 2x SSC/0.1% Tween 20) was added for 1 h at room temperature. Cells were then washed 3 times with PBS and blocked with 3% BSA/0.1% Tween 20 in 4x SSC for 20 min. FITC-conjugated goat anti-mouse antibody (Sigma) at 1:200 dilution in 2x SSC/0.1% Tween 20 was added for 1 h. Control filters were stained only with secondary antibody. Filters were washed 3 times with PBS, co-stained with propidium iodide (0.5 mg/ml) for 5 min, and washed 3 times with PBS. Filters were mounted on glass slides in Fluoro-Guard antifade reagent (BioRad, Hercules, CA, USA) and coverslips were applied. At least three different filters were analyzed for each experimental condition. Laser confocal fluorescence microscopy (Axiovert 100M, Zeiss, Germany) was performed at the UC Davis Medical Department Confocal Imaging Core Facility.
Permeability measurements
Transepithelial electrical resistance (TER) was measured with a 'chopstick' voltmeter (Evommeter, model EVOMX-G, World Precision Instruments, Sarasota, FL, USA). Resistance of tissue layers was corrected for the resistance of empty filters (approximately 100 W).
The permeability of Calu-3 cell sheets to Texas-red labeled BSA was evaluated by measuring the flux of tracer across the monolayer. The permeability was estimated assuming that the tracer flux was due to diffusional transport. 37 The relationship between the concentration of tracer in the bottom chamber [C b (t)] versus time and permeability (P) of the barrier is given by:
where V b and V t represent the volume in the top and bottom chambers (0.2 and 0.5 ml, respectively), T(t) is the total amount of tracer added to the system at time t, and A is the area of the cell sheet (0.33 cm 2 ). The permeability (P) of the membrane alone was measured in parallel so that the contribution of the cell sheet (P c ) was separated from the contribution due to the membrane (P m ), according to the relationship 1/P total = 1/P c + 1/P m where P total is the total permeability for the system.
Animal experiments
Fifteen male Sprague-Dawley rats weighing 350-400 g were used. Following anesthetization with Nembutal (35 mg/kg i.p.), a PE50 catheter was placed in the carotid artery and a tracheostomy with PE200 tubing was performed 3 tracheal rings above the carina. A perfused tracheal segment with intact systemic blood supply was formed as described previously. 38 In brief, a transverse incision was made through the ventral surface of the trachea just below the larynx and a second incision was made 14-16 mm caudal to the first. L-shaped catheters (1.5 mm OD) were tightly secured at both ends of the segment so formed and filled with saline at 38°C. One catheter was connected to a syringe. The tracheal segment was covered with plastic lining to prevent drying and heated with a lamp to 38-39°C under constant control of surface temperature. To measure transepithelial albumin flux, Evans Blue dye, which binds to plasma albumin, was injected intravenously (25 mg/kg). The solution in the tracheal lumen was completely replaced at 1-h intervals, and its Evans Blue content was determined from the absorbance at 615 nm (Turner spectrophotometer SP-380, Barnstead, Dubuque, IA, USA). The leukocyte content of tracheal fluid or blood was measured with a hemocytometer. Differential cell counts were performed with Diff-Quik staining (American Scientific Products, McGraw Park, IL, USA), following the formation of cell smears with a cytocentrifuge (Shandon Scientific, London, UK).
LPS (E. coli O55:B5; 100 mg/ml, 100 nM) was added to the luminal perfusate of the tracheal segment. One hour after recovery from surgery, Evans Blue dye (25 mg/kg) was infused into the bloodstream and samples of plasma and tracheal fluid (sample volume 1.5 ml) were taken hourly for 4 h. Ten rats received LPS and another five received vehicle alone.
In tests of pharmacological blockers of transduction pathways, each animal was used as its own control. Leukocyte migration was induced as described above and the period of induced leukocyte migration from 2-3 h was used as a baseline for each animal. After 3 h of tracheal perfusion with LPS alone, the tracheal segment was perfused for a further 1 h with LPS plus pharmacological agent (experimental period). The levels of leukocyte migration and albumin flux rate during the experimental period were compared with the same variables during the baseline period by paired t-test. The following pharmacological agents were added to the tracheal perfusate: (calphostin C, 10 -8 M, n = 5) and PD98059 (5 x 10 -5 M, n = 5).
Western blot analysis
Western blots were performed for phosphorylated ERK 1/2 (p-p44/p42) and total ERK1/2 (t-p44/p42). For in vitro experiments, samples from 6 filters were combined in 100 ml of ice-cold buffer. The epithelial cells were scraped off into a cold lysis buffer composed of 1% Triton X-100, 2 mM EDTA, 2 mM dithiothreitol, 0.25 mg/ml leupeptin, 0.25 mg/ml pepstatin A, 0.4 mg/ml aprotinin and 0.1 mM phenylmethylsulfonyl fluoride. The protein content of the lysate was determined with the BCA method (Pierce Endogen, Rockford, IL, USA). Samples (20 mg total protein) were separated on 10% sodium dodecyl sulfate (SDS) polyacrylamide gels and then the separated proteins were transferred to Nylon membranes, where they were blocked overnight at 4°C with 5% non-fat dry milk in TBST (10mM Tris-HCl, pH 8.0; 150 mM NaCl; 0.1% Tween 20). Next, the blot was rinsed twice with TBST and incubated for 2 h at room temperature with mouse monoclonal anti-phospho-p44/42 (ERK1/2) antibody in TBST containing 5% BSA. The membrane was then washed for 15 min with TBST and incubated with goat antimouse IgG conjugated with horseradish peroxidase in 5% milk for 1 h, and then washed 3 times with TBST and developed with enhanced chemiluminescence reagent (Amersham, Arlington, IL, USA). For total ERK, membranes were washed and re-probed with mouse monoclonal anti-p44/p42 in the same way. Staining was quantified using NIH Image v.1.6 software.
Statistical analyses
Data are presented as mean ± SEM. Comparison between means was performed by ANOVA followed by two-tailed Student's t-test with Bonferroni correction. P < 0.05 was regarded as statistically significant.
RESULTS
LPS initiated transepithelial migration of HL-60 cells across cultures of Calu-3
All experiments were performed in 6-8 cell cultures. LPS was added to the apical side of epithelial layers for 4-24 h. We did not observe changes in epithelial permeability or migration when LPS concentration was less than 10 mg/ml (data not shown). At 20 mg/ml, LPS initiated transmigration of HL-60 cells. In a series of preliminary experiments, we determined the optimal timing for assessment of migration, which was 4 h for neutrophillike HL-60 cells and 24 h for monocyte-like HL-60 cells (data not shown); during these periods, ~45% of cells transmigrated (Table 1) . Both spontaneous and induced migrations were 3-4-fold less in the mucosal-to-serosal Endotoxin induces leukocyte transmigration and changes in permeability of airway epithelium 59 direction, as compared to the serosal-to-mucosal direction (data not shown). Both calphostin C and PD98059 significantly reduced migration ( Fig. 1 ). As noted in the Materials and Methods section, to assure a specific action on the epithelium, pharmacological agents were added to epithelial cells, which were then washed twice before addition of LPS and/or HL-60 cells. We further investigated whether calphostin C and PD98059 would affect migration of HL-60 cells across empty filters. Tests were performed at 4 h for both monocyte-like and neutrophil-like HL-60 cells. Migration was induced by LPS-preconditioned medium, obtained from Calu-3 cultures treated with 20 mg/ml LPS for 4 h. There was no significant effect of either drug on spontaneous migration (data not shown). Induced migration towards LPS (20 mg/ml)-preconditioned medium across empty filters was completely blocked by both drugs. Migration induced by LPS-preconditioned medium was 21 ± 2%, calphostin C decreased it to 0 ± 10% (P = 0.01), and PD98059 decreased it to 0.4 ± 2% (P = 0.01).
Changes of TER and permeability to albumin of Calu-3 cells are associated with LPS toxicity
Changes in TER were not significant 4-24 h after media alone was added to the upper well (96 ± 7% of initial). Exposure to LPS (20 mg/ml) in the absence of HL-60 cells did not produce significant changes in TER or permeability to albumin over 4 h. After 24 h, TER decreased to 60 ± 7% of the initial value (P = 0.01). Over 24 h, LPS also increased permeability of epithelial layers to albumin to 60 Serikov, Choi, Schmiel, Skaggs, Fleming, Wu, Widdicombe Bar is 20 mm. blocked LPS-induced changes in TER (127 ± 31% of control; P = 0.03) and reduced permeability to albumin (to 64 ± 8% of control; P = 0.01). Calphostin C reduced changes in TER by LPS to 86 ± 9% of control (P = 0.04) and significantly reduced permeability to albumin (to 65 ± 6% of control; P = 0.001).
When non-stimulated neutrophil-like HL-60 cells were added to the upper well, TER did not decrease (100 ± 11% of control), but it decreased to 52 ± 8% of control (P = 0.002) over 4 h when neutrophil-like HL-60 cells were added with 20 mg/ml LPS (Fig. 1) . Changes in permeability to albumin showed the same pattern. Similar results were obtained with monocyte-like HL-60 cells (data not shown), though transmigration was several fold slower and comparable values of migration and permeability change were achieved in 24 h, as compared to 4 h for neutrophil-like HL-60 cells. In these cultures (Fig.1) , calphostin C significantly reduced LPS-induced changes in TER (103 ± 11% of initial; P = 0.003) and stabilized permeability to albumin (P = 0.004). PD98059 also restored LPS-induced changes in TER (90 ± 12% of initial; P = 0.03) and permeability to albumin (P = 0.03).
ERK1/2 is activated in epithelial cells in vitro by LPS
By immunostaining, we determined in Calu-3 cells after 4 h of LPS-induced migration of HL-60 cells (Fig. 2) and in cultures of primary epithelial cells with the human neutrophils after 12 h (Fig. 3) whether the administration of 20 mg/ml LPS caused phosphorylation of ERK1/2. For each study, layers from 2-3 different cultures were used. Immunostaining of Calu-3 and cow tracheal epithelial cells demonstrated that after 4 h both in the presence of LPS alone on the mucosal side and in the presence of LPS and leukocytes, epithelial cells became positively stained for phospho-ERK1/2 (Fig. 2) . To distinguish activation of ERK1/2 in epithelial cells from its activation in transmigrating granulocytes, granulocytes were stained with PKH26 (red fluorescence). As demonstrated in Figure 3 , we observed a strong positive staining for p-ERK1/2 in the epithelial cells that was not associated with labeled leukocytes. It is interesting to note that LPS caused a 'punctuate' pattern of ERK1/2 phosphorylation after 12 h of exposure. However, when human granulocytes were present, the pattern was different, i.e. 'diffuse' though remnants of a 'punctuate' pattern persisted in some areas.
Endotoxin induces leukocyte transmigration and changes in permeability of airway epithelium 61 Western blot analyses further confirmed the results of our morphological studies in Calu-3 cells (Fig. 4) . ERK1/2 phosphorylation was minimal when medium alone was added to the epithelium and was induced by LPS with or without the presence of HL-60 cells. Addition of HL-60 cells alone induced a moderate level of ERK phosphorylation, while LPS induced a high level of ERK phosphorylation. Addition of both HL-60 cells and LPS did not further increase the level of p-ERK1/2. In epithelial cells without HL-60 cells, both PD98059 and calphostin C blocked ERK1/2 phosphorylation (Fig. 4A) . In cultures of epithelial cells and migrating HL-60 cells, a similar reduction in the level of ERK1/2 phosphorylation was induced by PD98059 ( Fig. 4B ). Calphostin C, however, was without an effect on ERK1/2 phosphorylation induced by LPS indicating that in this case ERK1/2 activation occurred by some other, PKC-independent pathway.
Calphostin C and PD98059 attenuate transepithelial migration in rat tracheas
We further tested the effects of PD98059 and calphostin C in vivo in rat tracheas. When perfused with saline alone, there was no increase in transudation or leukocyte transmigration over the experimental period of 4 h. Our preliminary experiments showed that LPS at concentrations less than 100 mg/ml in the tracheal lumen did not result in leukocyte transmigration over a 2 h period (data not shown). Therefore, we used 100 mg/ml LPS to initiate migration. Two hours after LPS was added to the tracheal lumen, we observed a significant increase in the number of leukocytes in the tracheal lumen and the appearance of Evans Blue-labeled albumin. Peak migration during the period from 3-4 h corresponded to 100,000 cells/h/cm 2 of tracheal surface. Transudation of Evans Blue-labeled albumin increased in parallel with the appearance of leukocytes. As shown in vitro, calphostin C and PD98059 reduced both leukocyte migration and permeability to albumin (Fig. 5 ).
DISCUSSION
In three separate systems, we have shown that LPS initiates a breakdown in epithelial barrier function, which is associated with phosphorylation of ERK1/2 in epithelial cells. LPS also induced leukocyte transmigration across epithelium. Blockage of ERK1/2 and PKC (with calphostin C) reduced ERK1/2 phosphorylation, leukocyte transmigration, and the associated increase in the epithelial permeability. We found that LPS alone at high concentrations with and without the presence of leukocytes decreased TER and increased permeability to albumin in vitro. However, this effect occurred only after 24 h of exposure to LPS, while in the presence of immune cells similar changes in permeability occurred after 4 h. ERK1/2 phosphorylation was increased in epithelial cells as assessed by both immunocytochemistry and Western blots. PD98059 and calphostin C significantly reduced ERK1/2 phosphorylation. Since we pretreated epithelial layers with pharmacological agents before adding HL-60 cells or human neutrophils and then washed them, the agents were acting primarily on the epithelium. We conclude that LPS activates the ERK1/2 signaling cascade via PKC in airway epithelium, resulting in breakdown of epithelial barrier function, as summarized in Figure 6 .
We performed our in vitro experiments with two different cell types -the human airway epithelial cell line Calu-3 and with primary cultures of cow tracheal cells. Calu-3 cells are a spontaneously transformed cell line widely used for studies of barrier properties and electrolyte transport of the airway epithelium. Primary tracheal cultures and Calu-3 cells both resemble native epithelium in their TER. 39, 40 Calu-3 cells represented the best available immortal cell line for the study of human airway epithelium, as they produce layers with uniform permeability. Results of ERK1/2 phosphorylation initiated by LPS with Calu-3 cells and primary bovine cultures were similar.
LPS clearly induced epithelial ERK1/2 activation in the absence of leukocytes, and this was blocked by PD98059 and calphostin C. This finding is consistent with other data on the role of ERK in epithelial integrity of other cell lines. Thus, in Ras-transformed MDCK cells, PD98059 restored recruitment of occludin, claudin and ZO-1 to the cell membrane and increased transepithelial electrical resistance. 28 Thus down-regulation of the MAPK signaling pathway restores the barrier function of tight junctions. Of interest is the finding that addition of HL-60 cells alone caused some activation of ERK1/2, though it was lower than that induced by LPS. Migration of HL-60 cells initiated by LPS was not associated with phosphorylation of ERK1/2 above that induced by LPS alone, though it was associated with further increase in epithelial permeability. From our data ( Fig. 4) , it seems that PD98059 is more selective than calphostin C at inhibiting ERK1/2 in both epithelial cells and leukocytes; calphostin C failed to inhibit completely ERK1/2 in cultures of the epithelial cells in the presence of leukocytes after activation by LPS. We assume in this case that leukocytes, activated by LPS, in turn activated ERK1/2 in the epithelium by a mechanism independent of PKC. This may be contact activation or release of other inflammatory mediators, which acted through a redundant transduction pathway. In vivo, blockade of the LPS-induced increase in permeability by PD98059 and calphostin was also not complete. Therefore, other pathways may also be responsible for the breakdown of the epithelial barrier during LPS-induced leukocyte transmigration.
We performed several controls to determine whether the HL-60 cells or leukocytes in the epithelial layers were the possible source of elevated p-ERK1/2, as determined by Endotoxin induces leukocyte transmigration and changes in permeability of airway epithelium 63 Western blots. Morphologically, we observed less than 5% of migrating cells inside the epithelium, which is an indication that their contribution should be minimal. Also, in collected transmigrated cells, we were not able to determine a distinguishable amount of total ERK1/2. By confocal microscopy, we noted that the pattern of ERK1/2 activation was different when LPS alone was present ('punctate' pattern) as compared to when LPS and leukocytes were both present ('diffuse' pattern). Probably, activation of the epithelium by leukocytes and by the inflammatory mediators of activated leukocytes were additive, and the higher degree of ERK1/2 activation caused the switch from punctate to diffuse distribution.
Our findings further indicate that, in vivo, LPS also activates epithelium via PKC-ERK related pathways. Perfusion of rat tracheal lumen with LPS stimulated both leukocyte migration and plasma transudation into the lumen. The number of migrating leukocytes (~10 5 cells/h/cm 2 ) was similar to that previously reported for dog trachea perfused in vivo with IL-8. 41 Our data indicate that, though high concentrations of LPS (20 mg/ml) change permeability of the epithelium alone after 24 h exposure, in the presence of immune cells similar changes in permeability occur much earlier after only 4 h of exposure. This clearly indicates that immune cells are primarily responsible for activation and breakdown of the epithelial barrier integrity by LPS. LPS is recognized by a cluster of LPS receptors, which includes CD14, Toll-2 receptors and serum factors (LBP, soluble CD14). 12, 42 Soluble CD14 and LBP are required for activation of non-immune cells like epithelial cells. These factors are present in serum and, therefore, we used serum in our in vitro experiments. LPS may activate epithelium in many ways including release of chemokines by the epithelial cells or change in permeability of the epithelium associated with the tight junctions (electrical resistance), or trans-and paracellular transport of macromolecules (permeability to albumin). ERK1/2 are associated with the acto-myosin belt, which controls the functional status of the tight junctions. Transmigrating cells may activate the epithelium and change its electrical resistance and permeability to albumin as a secondary event (Fig.  6 ). We observed effects of calphostin C and PD98059 on leukocyte chemotaxis across the empty filters, so that in vivo the effects of these two blockers may be on both the epithelial cells and HL-60 cells.
Our observation that LPS has toxic effects on airway epithelium at high concentrations is consistent with previous findings. Previous studies have shown that at low concentrations (< 1 mg/ml), LPS has little effect on airway epithelial permeability, 3, 43 whereas at higher concentrations (> 100 mg/ml), LPS directly increases permeability. 4 At intermediate concentrations (40 mg/ml), LPS induces neutrophil transmigration in the airways. 6 The concentration of LPS in a thin (10-12 mm deep) layer of airway surface liquid is very difficult to assess. Measurement of LPS concentrations in bronchoalveolar lavage fluid 44, 45 of patients with pneumonia showed mean concentration of 5 endotoxin units/ml (~0.5 ng/ml) with the maximal concentration up to 500 endotoxin units/ml. The actual volume of airway surface liquid further diluted by lavage fluid is unknown. However, considering the possibility that the dilution ratio could easily be 1:1000, this gives an upper estimate of LPS concentration of about 50 mg/ml. In our experiments, we used different concentration of LPS in vivo and in vitro. In both cases, we performed a set of preliminary studies to determine the effective concentration of the specific preparation of LPS needed to achieve reasonable changes in TER and migration. There is a difference in the sensitivity to endotoxin between species. The differences in the effective LPS dose in vivo and in vitro may reflect species differences or differences in the extent of the mucosal mucus layers. It is possible that the mucus layer in rat trachea in vivo protects airway epithelium from endotoxin.
CONCLUSIONS
The blockade of PKC and ERK signaling pathways diminished or prevented the LPS-induced increases in epithelial permeability. Thus, the specific targeting of epithelial ERK1/2 pathways may lead to therapies aimed at restoring bronchial epithelial barrier function.
